The Effect of Dispensed Cannabis on Taxane-Induced Peripheral Neuropathy
Cannabinoids for Taxane-Induced Peripheral Neuropathy in Women Undergoing Breast Cancer Treatment
Sponsor: Thompson Family Foundation Initiative at Columbia University TFFI
Enrolling: Female Patients Only
Study Length: 8 Weeks
Clinic Visits: 5
IRB Number: 7635
U.S. Govt. ID: NCT03782402
Contact: Diana Martinez, MD: 646-774-7774 /
Additional Study Information: Paclitaxel is frequently used to treat breast cancer, but it can also cause neuropathy where the nerves of the hands and feet stop working properly. The symptoms of neuropathy can include pain, numbness, and difficulty with everyday activities like walking or typing. Paclitaxel-induced neuropathy is common and there are few treatment options. Our study will test the effect of cannabis (marijuana) capsules on neuropathy caused by paclitaxel (or docetaxel) in breast cancer patients. The capsules are provided by Tilray, a certified medical cannabis producer and the protocol is FDA approved. Our study lasts for 8 weeks, with several visits per month and careful monitoring. Compensation provided for time and travel.
This study is closed
Diana Martinez, MD
Do You Qualify?
Have you been diagnosed with breast cancer? Yes No
Did you receive Paclitaxel or Docetaxel as part of your treatment? Yes No
Did you develop neuropathy (nerve problems) as a result? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Diana Martinez, MD